Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-30 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 90,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-30 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 90,00 | 204,10 | Acquisition Under Employee Benefit Plan | 2,27 | 66,10k | 0,14% |
| 2026-04-30 | Ms. Susanne MunkstedChief Precision Medicine Officer | 89,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-30 | Ms. Susanne MunkstedChief Precision Medicine Officer | 89,00 | 201,83 | Acquisition Under Employee Benefit Plan | 2,27 | 324,23k | 0,03% |
| 2026-04-30 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 90,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-30 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 90,00 | 204,10 | Acquisition Under Employee Benefit Plan | 2,27 | 580,37k | 0,02% |
| 2026-03-02 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 100,00 | 200,41 | Kauf | 2,00 | 66,01k | 0,15% |
| 2026-03-02 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 100,00 | 200,41 | Kauf | 2,00 | 580,28k | 0,02% |
| 2026-03-02 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 100,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-03-02 | Ms. Susanne MunkstedChief Precision Medicine Officer | 99,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-03-02 | Ms. Susanne MunkstedChief Precision Medicine Officer | 99,00 | 198,40 | Kauf | 2,00 | 324,14k | 0,03% |
| 2026-03-02 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 100,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-23 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 117,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-23 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 117,00 | 201,91 | Kauf | 1,73 | 580,83k | 0,02% |
| 2025-12-23 | Ms. Susanne MunkstedChief Precision Medicine Officer | 117,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-23 | Ms. Susanne MunkstedChief Precision Medicine Officer | 117,00 | 201,91 | Kauf | 1,73 | 324,04k | 0,04% |
| 2025-12-23 | Ms. Jillian BeggsInsider | 117,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-23 | Ms. Jillian BeggsInsider | 117,00 | 201,91 | Kauf | 1,73 | 189,46k | 0,06% |
| 2025-12-23 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 117,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-23 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 117,00 | 201,91 | Kauf | 1,73 | 66,56k | 0,18% |
| 2025-11-28 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 95,00 | 199,95 | Kauf | 2,10 | 66,44k | 0,14% |
| 2025-11-28 | Ms. Jillian BeggsInsider | 95,00 | 199,95 | Kauf | 2,10 | 189,35k | 0,05% |
| 2025-11-28 | Ms. Susanne MunkstedChief Precision Medicine Officer | 95,00 | 199,95 | Kauf | 2,10 | 323,92k | 0,03% |
| 2025-11-28 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 95,00 | 199,95 | Kauf | 2,10 | 580,71k | 0,02% |
| 2025-11-28 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 95,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-28 | Ms. Susanne MunkstedChief Precision Medicine Officer | 95,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-28 | Ms. Jillian BeggsInsider | 95,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-28 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 95,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-03 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 92,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-03 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 92,00 | 195,92 | Kauf | 2,13 | 580,62k | 0,02% |
| 2025-11-03 | Ms. Susanne MunkstedChief Precision Medicine Officer | 94,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-03 | Ms. Susanne MunkstedChief Precision Medicine Officer | 94,00 | 200,18 | Kauf | 2,13 | 323,83k | 0,03% |
| 2025-11-03 | Ms. Jillian BeggsInsider | 92,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-03 | Ms. Jillian BeggsInsider | 92,00 | 195,92 | Kauf | 2,13 | 189,25k | 0,05% |
| 2025-11-03 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 92,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-03 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 92,00 | 195,92 | Kauf | 2,13 | 66,35k | 0,14% |
| 2025-10-01 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 91,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-10-01 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 91,00 | 202,34 | Kauf | 2,22 | 580,53k | 0,02% |
| 2025-10-01 | Ms. Susanne MunkstedChief Precision Medicine Officer | 91,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-10-01 | Ms. Susanne MunkstedChief Precision Medicine Officer | 91,00 | 202,34 | Kauf | 2,22 | 323,73k | 0,03% |
| 2025-10-01 | Ms. Jillian BeggsInsider | 91,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-10-01 | Ms. Jillian BeggsInsider | 91,00 | 202,34 | Kauf | 2,22 | 189,16k | 0,05% |
| 2025-10-01 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 91,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-10-01 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 91,00 | 202,34 | Kauf | 2,22 | 66,26k | 0,14% |
| 2025-09-01 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 107,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-09-01 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 107,00 | 202,95 | Kauf | 1,90 | 580,43k | 0,02% |
| 2025-09-01 | Ms. Susanne MunkstedChief Precision Medicine Officer | 107,00 | 202,95 | Kauf | 1,90 | 323,64k | 0,03% |
| 2025-09-01 | Ms. Jillian BeggsInsider | 107,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-09-01 | Ms. Jillian BeggsInsider | 107,00 | 202,95 | Kauf | 1,90 | 189,07k | 0,06% |
| 2025-09-01 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 107,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-09-01 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 107,00 | 202,95 | Kauf | 1,90 | 66,17k | 0,16% |
| 2025-09-01 | Ms. Susanne MunkstedChief Precision Medicine Officer | 107,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-29 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 111,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-29 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 111,00 | 199,88 | Kauf | 1,80 | 619,45k | 0,02% |
| 2025-07-29 | Ms. Susanne MunkstedChief Precision Medicine Officer | 111,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-29 | Ms. Susanne MunkstedChief Precision Medicine Officer | 111,00 | 199,88 | Kauf | 1,80 | 323,53k | 0,03% |
| 2025-07-29 | Ms. Jillian BeggsInsider | 111,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-29 | Ms. Jillian BeggsInsider | 111,00 | 199,88 | Kauf | 1,80 | 188,96k | 0,06% |
| 2025-07-29 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 111,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-29 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 111,00 | 199,88 | Kauf | 1,80 | 619,45k | 0,02% |
| 2025-07-22 | Mr. Ryan KeelingCEO & Director | 271,69k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-22 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 189,75k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-22 | Ms. Susanne MunkstedChief Precision Medicine Officer | 88,19k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-22 | Ms. Jillian BeggsInsider | 83,77k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-22 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 194,06k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-22 | Ms. Sandra BlakeCPO | 86,25k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-06-27 | Mr. Jordan Russell ClarkChief Data Officer? & Executive Director | 124,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-06-27 | Ms. Susanne MunkstedChief Precision Medicine Officer | 124,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-06-27 | Ms. Jillian BeggsInsider | 124,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-06-27 | Mr. Nicholas Stewart RobertsCFO, Secretary & Director | 124,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
